News

News Archive

Radius health & Menarini group provide elacestrant update

Radius health & Menarini group provide elacestrant update

The target enrollment milestone has been reached in the Phase 3 EMERALD clinical trial of elacestrant. Elacestrant is an oral Selective Estrogen Receptor Degrader (SERD) that is being...
Menarini Ricerche Announces Dose Escalation Results Of The Clinical Trial Of Men1611 In Breast Cancer

Menarini Ricerche Announces Dose Escalation Results Of The Clinical Trial Of Men1611 In Breast Cancer

Menarini Ricerche, the R&D division of the Menarini Group, today announced the results of the dose escalation part of its B-PRECISE-01 clinical trial (NCT03767335) which is...
Menarini Ricerche Announces Initiation of Cohort Expansion for the Clinical Study of SEL24/MEN1703 in Acute Myeloid Leukemia

Menarini Ricerche Announces Initiation of Cohort Expansion for the Clinical Study of SEL24/MEN1703 in Acute Myeloid Leukemia

Menarini Ricerche, the R&D division of the Menarini Group, announced today that it has treated the first patient in Europe for the cohort expansion part of DIAMOND-01 clinical trial
International Fair Play Menarini award 2020

International Fair Play Menarini award 2020

Italian and international sport legends shone at the awards ceremony in Piazza del Municipio in Castiglion Fiorentino

Announced the xxiv edition of the international fair play Menarini award

Announced the xxiv edition of the international fair play Menarini award

The spotlight is on the XXIV International Fair Play Menarini Award , which was officially presented in Rome. The 2020 programme and winners were revealed in the presence of CONI (The...

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More